SynthesisMedicina (Kaunas, Lithuania)2024

Efficacy and Safety of Evolocumab and Alirocumab as PCSK9 Inhibitors in Pediatric Patients with Familial Hypercholesterolemia: A Systematic Review and Meta-Analysis.

Guoguang Xiao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.